NA00937
DNA from Fibroblast
Description:
PHENYLKETONURIA
|
Repository
|
NIGMS Human Genetic Cell Repository
|
| Subcollection |
Heritable Diseases |
| Class |
Disorders of Amino Acid Metabolism |
| Quantity |
10 µg |
| Quantitation Method |
Please see our FAQ |
|
Cell Type
|
Fibroblast
|
|
Transformant
|
Untransformed
|
|
Sample Source
|
DNA from Fibroblast
|
|
Race
|
White
|
|
Relation to Proband
|
proband
|
|
Confirmation
|
Clinical summary/Case history
|
|
Species
|
Homo sapiens
|
|
Common Name
|
Human
|
|
Remarks
|
|
| PDL at Freeze |
5.23 |
| Passage Frozen |
4 |
| |
| IDENTIFICATION OF SPECIES OF ORIGIN |
Species of Origin Confirmed by Nucleoside Phosphorylase Isoenzyme Electrophoresis |
| |
| Gene |
PAH |
| Chromosomal Location |
12q24.1 |
| Allelic Variant 1 |
261600.0031; PHENYLKETONURIA |
| Identified Mutation |
PHE39LEU; See Forrest et al. (1991).
|
| |
| Gene |
PAH |
| Chromosomal Location |
12q24.1 |
| Allelic Variant 2 |
; PHENYLKETONURIA |
| Identified Mutation |
IVS10-11G>A |
| Remarks |
Clinically affected; normal level of dihydropteridine reductase in skin fibroblasts; donor subject is a compound heterozygote: one allele has a C>G transversion at nucleotide 117 in exon 2 of the PAH gene [117C>G] resulting in a substitution of leucine for phenylalanine at codon 39 [Phe39Leu (F39L)] and a second allele has a splice site mutation at nucleotide 1066 [IVS10-11G>A]. |
| Veleva D, Ay M, Ovchinnikov DA, Prowse ABJ, Menezes MJ, Nafisinia M, Generation of fibroblast-derived induced pluripotent stem cell (iPSC) lines from two paediatric patients with phenylketonuria Stem cell research77:103405 2024 |
| PubMed ID: 38555716 |
| |
| Veleva D, Ay M, Ovchinnikov DA, Prowse ABJ, Menezes MJ, Nafisinia M, Generation of two lymphoblastoid-derived induced pluripotent stem cell (iPSC) lines from patients with phenylketonuria Stem cell research77:103407 2024 |
| PubMed ID: 38552357 |
|
|